Ovid Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Ovid Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Ovid Therapeutics Inc
Rating: 2.39158325
Author: Trendlyne DVM scores

about

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated ...

1.23 -0.06 (-4.65%)

412.50% Gain from 52W Low

1.5M

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

16.8 / 100

Technically Bullish

78.8 / 100

1Yr Price target upside is 176%

5 analysts

Ovid Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ovid Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated ...

412.50% Gain from 52W Low

SWOT Analysis

Ovid Therapeutics Inc Live Price Chart